ALHC

SAN FRANCISCO--(BUSINESS WIRE)--Shareholder rights firm Hagens Berman (HBSS) is investigating potential securities law violations by Alignment Healthcare, Inc. (NASDAQ: ALHC) following a whistleblower lawsuit alleging systemic financial manipulation.SUBMIT YOUR ALHC INVESTMENT LOSSES TO HBSSVisit: www.hbsslaw.com/investor-fraud/alhcContact the Firm Now: ALHC@hbsslaw.com, 844-916-0895Alignment Healthcare, Inc. (ALHC) Investigation:On July 8, 2026, news broke that a former Alignment executive had.

ORANGE, Calif., July 09, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), will release its second quarter 2026 financial results on Thursday, July 30, 2026, after market close.

SAN FRANCISCO, July 08, 2026 (GLOBE NEWSWIRE) -- National shareholder rights firm Hagens Berman (HBSS) is investigating potential violations of U.S. securities laws by Alignment Healthcare, Inc. (NASDAQ: ALHC) following reports of a whistleblower lawsuit alleging systemic financial manipulation. SUBMIT YOUR ALHC INVESTMENT LOSSES TO HBSS Visit: www.hbsslaw.com/investor-fraud/alhc Contact the Firm Now: ALHC@hbsslaw.com 844-916-0895 Alignment Healthcare, Inc. (ALHC) Investigation: On July 8, 2026, news broke that a former Alignment Healthcare executive had filed a lawsuit alleging the company engaged in deliberate accounting irregularities to inflate its financial results.

SAN DIEGO, July 08, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) on behalf of investors who suffered losses and whether those losses may be recoverable under federal securities laws.

Alignment Healthcare is using AI automation, quality plans and complex-care growth to improve Medicare Advantage economics while cost and rule pressures remain.

Alignment Healthcare's improved profits, raised 2026 outlook and stronger cash flow support the bull case, but its big rally and richer valuation raise the buy bar.

Alignment Healthcare's Medicare Advantage growth, quality ratings and automation gains are lifting profitability, but 2026 execution risks remain.

Here is how Alignment Healthcare (ALHC) and DaVita HealthCare (DVA) have performed compared to their sector so far this year.

Konowiecki sold 25,000 shares for a transaction value of $550,000 at around $22.00 per share on June 18, 2026. The sale represented 2.1% of his direct holdings, with 1,153,816 shares remaining post-transaction.

ALHC, AGX, AGYS and CIEN make the cut as the top liquid stocks, each boasting strong liquidity, growth attributes and operational efficiency.